Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma

International Journal of Oncology

Volumn 29, Issue 1, 2006, Pages 117-124

  Sakuma, Takumi ^a   Uzawa, Katsuhiro ^b,c   Onda, Takeshi ^a   Shiiba, Masashi ^c   Yokoe, Hidetaka ^c   Shibahara, Takahiko ^a   Tanzawa, Hideki ^b,c  

^a TOKYO DENTAL COLLEGE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

HDAC6; Immunofluorescence; Immunohistochemistry; Oral squamous cell carcinoma; Quantitative real time RT PCR; Western blotting

Indexed keywords

HDAC6 PROTEIN, HUMAN; HISTONE DEACETYLASE; MESSENGER RNA;

AGED; ARTICLE; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; RNA, MESSENGER; UP-REGULATION;

EID: 34547882857     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.1.117     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Macfarlane GJ, Zheng T, Marshall JR, et al: Boyle P. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 31: 181-187, 1995.
3. Mashberg A, Boffetta P, Winkelman R and Garfinkel L: Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72: 1369-1375, 1993.
4. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
5. Marshall CJ: Tumor suppressor genes. Cell 64: 313-326, 1991.
6. Jenuwein T and Allis CD: Translating the histone code. Science 293: 1074-1080, 2001.
7. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A and Ponte JF: Histone deacetylases: unique players in shaping the epigenetic histone code. Ann NY Acad Sci 983: 84-100, 2003.
8. Wolffe AP: Chromatin remodeling: why it is important in cancer. Oncogene 20: 2988-2990, 2001.
9. Loidl P: Towards an understanding of the biological function of histone acetylation. FEBS Lett 227: 91-95, 1988.
10. Roth SY, Denu JM and Allis CD: Histone acetyltransferases. Annu Rev Biochem 70: 81-120, 2001.
11. Timmermann S, Lehrmann H, Polesskaya A and Harel-Bellan A: Histone acetylation and disease. Cell Mol Life Sci 58: 728-736, 2001.
12. Pandolfi PP: Transcription therapy for cancer. Oncogene 20: 3116-3127, 2001.
13. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM and Albagli O: The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 26: 4645-4651, 1998.
14. Gray SG and Ekstrom TJ: The human histone deacetylase family. Exp Cell Res 262: 75-83, 2001.
15. Zhou X, Marks PA, Rifkind RA and Richon VM: Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci USA 98: 10572-10577, 2001.
16. Verdin E, Dequiedt F and Kasler HG: Class II histone deacetylases: versatile regulators. Trends Genet 19: 286-293, 2003.
17. Verdel A and Khochbin S: Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation- dependent chromatin modifiers. J Biol Chem 274: 2440-2445, 1999.
18. Grozinger CM, Hassig CA and Schreiber SL: Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96: 4868-4873, 1999.
19. Hubbert C, Guardiola A, Shao R, et al: HDAC6 is a microtubule-associated deacetylase. Nature 417: 455-458, 2002.
20. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM and Schreiber SL: Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100: 4389-4394, 2003.
21. Matsuyama A, Shimazu T, Sumida Y, et al: In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 21: 6820-6831, 2002.
22. Yoshida N, Omoto Y, Inoue A, et al: Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated gene. Cancer Sci 95: 496-502, 2004.
23. Koike H, Uzawa K, Nakashima D, et al: Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27: 59-67, 2005.
24. Kasamatsu A, Uzawa K, Shimada K, et al: Elevation of galectin-9 as an inflammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo. Int J Biochem Cell Biol 37: 397-408, 2005.
25. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum Ca (2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 110: 225-231, 2004.
26. Kasamatsu A, Uzawa K, Nakashima D, et al: Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 16: 269-273, 2005.
27. Shimada K, Uzawa K, Kato M, et al: Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915-1921, 2005.
28. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H and Tanzawa H: Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82: 607-611, 2003.
29. Ayer DE: Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol 9: 193-198, 1999.
30. Narlikar GJ, Fan HY and Kingston RE: Cooperation between complexes that regulate chromatin structure and transcription. Cell 108: 475-487, 2002.
31. Freiman RN and Tjian R: Regulating the regulators: lysine modifications make their mark. Cell 112: 11-17, 2003.
32. Kouzarides T: Histone methylation in transcriptional control. Curr Opin Genet Dev 12: 198-209, 2002.
33. Polevoda B and Sherman F: The diversity of acetylated proteins. Genome Biol 3: Reviews 0006: 1-6, 2002.
34. Richon VM, Sandhoff TW, Rifkind RA and Marks PA: Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97: 10014-10019, 2000.
35. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T and Kelly WK: Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1: 194-202, 2001.
36. Miller TA, Witter DJ and Belvedere S: Histone deacetylase inhibitors. J Med Chem 46: 5097-5116, 2003.
37. Cress WD and Seto E: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184: 1-16, 2000.
38. Johnstone RW and Licht JD: Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 4: 13-18, 2003.
39. Bali P, Pranpat M, Bradner J, et al: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 280: 26729-26734, 2005.
40. Voelter-Mahlknecht S and Mahlknecht U: Cloning and structural characterization of the human histone deacetylase 6 gene. Int J Mol Med 12: 87-93, 2003.